Phesgo

Phesgo

Basic Prescribing Info
Contents
Per 600 mg/600 mg vial Pertuzumab 600 mg, trastuzumab 600 mg. Per 1,200 mg/600 mg vial Pertuzumab 1,200 mg, trastuzumab 600 mg
MIMS Class
Targeted Cancer Therapy
ATC Classification
L01FY01 - pertuzumab and trastuzumab ; Belongs to the class of combinations of monoclonal antibodies and antibody drug conjugates. Used in the treatment of cancer.
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in